🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

J. Gregory Cairncross

University of Calgary

ORCID: 0000-0002-5169-5039

Also affiliated with University of Toronto, Alberta Bible College, Alberta Cancer Foundation, Alberta Bone and Joint Health Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial”.

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

The Lancet Oncology(2009)10.1016/s1470-2045(09)70025-7
N/A
1.3DataRank · unranked
7738 citations

Monika E. Hegi, Martin J. van den Bent, Martin JB Taphoorn, Robert C. Janzer, Samuel K. Ludwin +25 more

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

New England Journal of Medicine(2005)10.1056/nejmoa043331
N/A
1.3DataRank · unranked
7181 citations

Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller +15 more

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Neuro-Oncology(2020)10.1093/neuonc/noaa168
N/A
0DataRank · unranked
116 citations

Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown +18 more